Initial Results After Launch of Best Practice Advisory for Contraindicated Agents in Parkinson’s Disease and Related disorders
Objective: To describe factors associated with triggering a best practice advisory (BPA) for dopamine-blocking agents (DBA) and report preliminary outcomes in hospitalized persons with Parkinson’s…Pain types in multiple system atrophy: results from a community-based survey
Objective: To assess the frequency of different pain types in multiple system atrophy (MSA). Background: According to a recent meta-analysis, up to 60% of individuals…Prospective Study of Gait and Multimodal MRI Biomarkers for Multiple System Atrophy
Objective: We aimed to develop new multimodal biomarkers allowing objective monitoring of early MSA progression to improve outcome definition for future neuroprotective trials. Background: MSA…Prevalence of autonomic symptoms in Multiple System Atrophy on the background of probable RBD
Objective: To discover whether having probable rapid eye movement sleep behavior disorder (RBD) affects prevalence of particular autonomic symptoms, namely falls, constipation and urinary incontinence…The impact of stimulation setting on Battery Longevity in Deep Brain Stimulation
Objective: This study aims to assess the estimated battery longevity and its determinants in Percept model of Deep Brain Stimulation (DBS) devices in patients diagnosed…24-Hour Ambulatory Blood Pressure Monitoring and Dipping Patterns in Parkinson’s Disease and Multiple System Atrophy
Objective: To depict 24-hour blood pressure profile, especially dipping patterns, in individuals diagnosed with Parkinson’s Disease (PD) and Multiple System Atrophy (MSA). Background: Both PD…Integrating Parkinson’s Plus Cohorts into the Global Parkinson’s Genetics Program
Objective: To integrate Parkinson’s Plus Cohorts into the Global Parkinson’s Genetics Program (GP2) and design a dictionary of data to be collected. Background: GP2 is…Risk Factors Of Parkinson’s Disease A Case-Control Study In Tunisian Patients
Objective: To investigate the role of family, environmental and professional factors in Parkinson's disease (PD) development. Background: Parkinson's disease (PD) is a neurological disorder with…Manganese-induced Parkinsonism Vs Rotenone-induced Parkinsonism: Animal Life Matters!
Objective: To evaluate the Parkinsonism mimicking potential of MnCl2 in an experimental rat model.To compare the destructive effect of MnCl2 with rotenone by performing behavioral,…Baseline and Longitudinal NSD-ISS Staging of the PPMI Cohort
Objective: To apply biological definition and Neuronal α-Synuclein Disease Integrated Staging System (NSD-ISS) to the PPMI baseline and longitudinal dataset. Background: The NSD-ISS Working Group…
- « Previous Page
- 1
- …
- 16
- 17
- 18
- 19
- 20
- …
- 1554
- Next Page »